“Clinical cannabis has become a therapeutic compass to what modern medicine fails to cure”.

– Dr. Ethan Russo

Who We Are


Anandamida Gardens SAS is a Colombian Company licensed for the cultivation and fabrication of cannabis derivatives with medicinal purposes dedicated to the research and popularization of the endocannabinoid science.

We are a multi disciplinary team conformed by health professionals, scientists and professionals in different areas with more than 10 years of experience in the study of medicinal cannabis and its therapeutic possibilities.

What We Do


In Anandamida Gardens we grow Cannabis and develop medicines for the treatment of chronic disease through modulation of the endocannabinoid system.
We design divulgative processes to contribute to the education of a growing community of healthcare professionals, caregivers and patients around the globe, who want to learn about the science behind the cannabinoid therapies and its interactions with the endocannabinoid system.

Endomedicine and education


Endomedicine is a medical focus area dealing with the prevention,diagnosis and treatment of chronic diseases through the modulation of human endocannabinoid system (ECS).
Anandamida offers continuing education about the endocannabinoid system, the cannabis plant and its applications and the modulatory therapies of the endocannabinoid system (MTECS).

 

Our work

 

 

We have achieved brand recognition in Colombia and Latin America. Our cultivars are registered with the Colombian Agropecuary Institute (ICA) and we are getting ready for commercial production for local and export markets.
We have developed cannabinoid formulas rich in terpenoids for the treatment of chronic diseases and we have a broad medical network in Colombia, which we support with continuing education programs.
Along with our medical team, we have proposed dosing strategies and follow up protocols to help the clinicians make the best decisions offering the patient quality information for the understanding of its endomedicine treatment or the modulation of the ECS through the MTECS.

BOARD OF ADVISORS

Doctor Ethan Russo

Ethan Russo
Neurologist and Researcher

Medical Director at CReDO Science USA

Mara Gordon
Chief Process Engineer and Researcher

Co-Founder at Aunt Zelda’s
California USA

Doctora Paola Pineda

Paola Pineda
Medicine Doctor and Researcher

Medical Director at Grupo Curativa Colombia

Cristina Sánchez
Biologist and Researcher

Professor at Universidad Complutense de Madrid

Doctor José Rodriguez Orengo

José Rodriguez Orengo
Pharmaceutical Chemist and Researcher

Professor at Universidad de Puerto Rico

Garret Seale

Garrett Seale
Neurocientífico e Investigador

BS Brown University
PHD Columbia University
USA